MORE diabetes sufferers will be
able to access Byetta (exanatide)
from today, with an expanded
PBS listing making it available on
streamlined authority as an add-on
therapy to insulin plus metformin
for patients with type 2 diabetes.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 01 Oct 15
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Oct 15
